Effects of insulin growth factor I and bone morphogenetic protein-2 combined application on promoting proliferation and differentiation of MC 3T3-E1 and NIH 3T3 cells

JIN Dong-mei,CHEN Li-li,YAN Jie
DOI: https://doi.org/10.3969/j.issn.1003-9872.2006.03.013
2006-01-01
Abstract:Objective To demonstrate the effects of recombinant human insulin-like growth factor I (rhIGF-I) or recombinant human bone morphogenetic protein-2 (rhBMP-2) and combined application of the two cytokines on proliferation and differentiation of MC 3T3-E1 cells and NIH 3T3 cells. Methods Mouse osteobalast-like cell MC3T3-E1 and mouse fibroblast cell NIH3T3 were treated with different dosages of rhIGF-I or rhBMP-2 and rhIGF-I plus rhBMP-2. Proliferations of the two cells were measured by methylthiazol tetrazolium(MTT)method. Differentiations of the two cells were examined by using alkaline phosphatase(ALP)measurement kit. Radioimmunoassay was applied to detect levels of osteocalcin (OC) secreted by the two cells. Results MC 3T3-E1 cells and NIH 3T3 cells treated with 1~75 ng/ml rhIGF-I and 10~100 ng/ml rhBMP-2 showed obvious effects of promoting proliferation (P<0.01) and increasing activities of cellular ALP (P<0.05). The results of MTT examinations were similar by using the same different concentrations of rhIGF-I and rhBMP-2 treated for 8, 24 and 48 h, respectively. RhIGF-I plus rhBMP-2 showed stronger effects on promoting proliferation and increasing cellular ALP activities for both the two cells than using any one of the two cytokines (P<0.05). However, no significant changes in levels of OC secreted by the two cells was found when using different dosages of rhIGF-I or rhBMP-2 and rhIGF-I plus rhBMP-2(P>0.05). Conclusion rhIGF-I and rhBMP-2 had synergistical effects on promoting cell proliferation and early cell differentiation depending on the used dosages, but they had no significant effects on promoting advanced cell differentiation.
What problem does this paper attempt to address?